|
|
Other links at Articles > Cardiology |
| 1. |
Regular Fasting May Improve CVD Risk
|
|
|
An observational study of Latter-day Saints Mormons suggests that fasting may be a key driver of reduced cardiovascular disease in this group. Medscape Medical News
|
| 4. |
MEND-CABG II: No Benefit of MC-1 in Reducing Death/MI Post-CABG
|
|
|
The lead investigator says the drug, based on a metabolite of vitamin B6, likely has no future as a cardioprotective agent in bypass surgery but may yet prove to have other beneficial metabolic properties, provided its developer has deep enough pockets to continue to study it. Heartwire
|
| 5. |
First Data on Aliskiren in Diabetic Nephropathy
|
|
|
The first trial of the new direct renin inhibitor, aliskiren, in patients with diabetic nephropathy shows that it reduces proteinuria when added to conventional treatment. But observers say this is merely a surrogate-end-point trial and definitive guidance on how to use this drug in such patients will come only from an ongoing large outcomes study, ALTITUDE. Heartwire
|
|
|
